Floatz logo

METHOTREXATE

Malignant Pleural Effusion

Peking Union Medical CollegeSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Malignant Pleural Effusion cohort.

Asset / SponsorPhaseRating
Carboplatin
University of Washington
Phase 2BB
(+)-VINCRISTINE
Peking University Cancer Hospital & Institute
Phase 3BB
Irinotecan
Peking University Cancer Hospital & Institute
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
Chinese PLA General Hospital
Phase 3BB
Inno-206
City of Hope Medical Center
Phase 2BB

View all 27 →

Same molecule, other indications

METHOTREXATE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
acute promyelocytic leukemiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →